Aranesp

Lea en español

AranespAranesp is the trade name for Darbepoetin alfa, a synthetic version of erythropoietin, which stimulates the production of red blood cells. Aranesp has been used since its approval by the U.S. Food and Drug Administration (FDA) in 2001 to treat patients with anemia, as well as chronic renal failure. It has been frequently prescribed to individuals suffering anemia as a byproduct of chemotherapy.
The FDA has required black box warnings on all sales of Darbepoetin alfa in the United States, citing a number of potential adverse health risks, including:

  • Myocardial infarction, or heart attack, as well as congestive heart failure
    Hypertension (high blood pressure), with increased risk of stroke
  • Venous thromboembolism
  • Thrombosis of vascular access
  • Tumor progression or recurrence

If you experienced side effects after being prescribed Aranesp, GetLegal has the tools and resources to help you find skilled legal representation to protect your rights. Visit our attorney directory, look for your geographic location and find the best lawyer for your situation.

Defective Drugs & Medical Devices Topics

Latest Articles

Four Things to Know About Traffic Stops

  You’re driving down the road; you glance down at the speedometer and see that you’re driv…

11 Dec 2018, Tuesday

Small Claims Court: An Overview

  Let’s say that you have a dispute with your landlord. You were asked to pay a security depo…

10 Dec 2018, Monday

Divorce and Taxes

  If you are facing a divorce, you know that there are plenty of difficult, even painful questi…

07 Dec 2018, Friday